Dr. Adam M. Boruchov, MD

Dr. Boruchov practices at Northwell Danbury Hospital in Danbury, Connecticut, part of Northwell Health.

Dr. Boruchov's NPI, 1851362883, was assigned on January 28, 2006. Dr. Boruchov graduated from SUNY Downstate Health Sciences University in 1997. Dr. Boruchov's Connecticut license number on file is 46499.

Dr. Boruchov's primary practice is Northwell Danbury Hospital, at 24 Hospital Ave, Danbury, CT 06810 in Fairfield County. The practice phone is (203) 739-7000.

Dr. Boruchov's primary practice is Northwell Danbury Hospital in Danbury, Connecticut, part of Northwell Health. Dr. Boruchov is also affiliated with Saint Francis Hospital. The medical group on file is Trinity Health Of New England Medical Group. Dmand AI also links Dr. Boruchov to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boruchov practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Boruchov's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Boruchov is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Boruchov's licenses on file in 2 states: Connecticut and New York.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Boruchov treats.

CMS data shows 79 Medicare services from Dr. Boruchov across 3 procedure codes in 2024, for 28 Medicare patients. Medicare paid $8,815 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Boruchov in 2024. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boruchov's median patient age at 76, with 47% women.

In 2024, Dr. Boruchov wrote 34 Medicare Part D claims for 12 patients. 32% of them were for generic drugs. They cover 10 drugs, with $1,429,452 in total drug cost. In 2022, CMS named 263 claims across 9 drugs.

Dr. Boruchov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Boruchov, published from 2004 to 2025. 2010 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Multiple Myeloma and Antigens, CD. Dr. Boruchov has published most often in Am J Hematol. Dr. Boruchov's most frequent co-authors are James W. Young, MD, Matthew S. Davids, MD and David Christopher Fisher, MD.

Dmand AI links Dr. Boruchov to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Myeloma, Purpura, Thrombocytopenic, Idiopathic and Blood Protein Disorders.

CMS Open Payments shows 114 general payments to Dr. Boruchov from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 86% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $61,017.

Dr. Boruchov graduated from SUNY Downstate Health Sciences University in 1997. Dr. Boruchov is a member of ASCO.

Dr. Boruchov is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.